Pharmaceutical compositions comprising GLP-1 peptides or exendin-4 and a basal insulin peptide

Pharmaceutical composition for parenteral administration comprising a basal insulin peptide and an insulinotropic GLP-1 peptide comprising at least 6 zinc atoms per 6 insulin molecules. 用于胃肠外给药的药物组合物，其包括基础胰岛素肽和促胰岛素GLP-1肽，并且包含至少6个锌原子/6个胰岛素分子。...

Full description

Saved in:
Bibliographic Details
Main Authors PLUM ANNE, SCHLEIN MORTEN, THOMSEN JENS KAALBY, POULSEN CHRISTIAN, MARCUSSEN ANNE SOFIE KJAER, STEENSGAARD DORTE BJERRE
Format Patent
LanguageChinese
English
Published 01.12.2017
Subjects
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Online AccessGet full text

Cover

More Information
Summary:Pharmaceutical composition for parenteral administration comprising a basal insulin peptide and an insulinotropic GLP-1 peptide comprising at least 6 zinc atoms per 6 insulin molecules. 用于胃肠外给药的药物组合物，其包括基础胰岛素肽和促胰岛素GLP-1肽，并且包含至少6个锌原子/6个胰岛素分子。
Bibliography:Application Number: CN201710279962